Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
cpmp/bpwg/282/00
cpmp/ bpwg/ 282/ 00
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
emea/cpmp/bpwg/1089/00
emea/ cpmp/ bpwg/ 1089/ 00
Last Update: 2012-04-12
Usage Frequency: 8
Quality:
arbeitsgruppe blut und plasma (bpwg)
groupe de travail «sang et plasma» (bpwg)
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
emea/cpmp/bpwg/388/95 rev.
1
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
dokumentennummer emea/cpmp/bpwg/283/00
numéro de référence emea/ cpmp/ bpwg/ 283/ 00
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
emea/cpmp/phvwp/bpwg / 2231/99
1
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
emea/cpmp/bpwg/198/95 rev.1 note
emea/cpmp/bpwg/198/95 rev.1
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cpmp/bpwg/3226/99 cpmp/bpwg/283/00
cpmp/ bpwg/ 3226/ 99 cpmp/ bpwg/ 283/ 00
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cpmp-ad-hoc-arbeitsgruppe blutprodukte dokumentennummer cpmp/bpwg/2220/99
groupe de travail ad hoc du cpmp sur les produits sanguins numéro de référence cpmp/ bpwg/ 2220/ 99
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/or intramuscular use (cpmp/bpwg/574/99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.